Woster PM - Search Results

1

Effect of pro-inflammatory cytokines on the toxicity of the arylhydroxylamine metabolites of sulphamethoxazole and dapsone in normal human keratinocytes.

Khan FD, Roychowdhury S, Nemes R, Vyas PM, Woster PM, Svensson CK. Khan FD, et al. Among authors: woster pm. Toxicology. 2006 Feb 1;218(2-3):90-9. doi: 10.1016/j.tox.2005.10.002. Epub 2005 Nov 14. Toxicology. 2006. PMID: 16289751

2

Reactive oxygen species generation and its role in the differential cytotoxicity of the arylhydroxylamine metabolites of sulfamethoxazole and dapsone in normal human epidermal keratinocytes.

Vyas PM, Roychowdhury S, Woster PM, Svensson CK. Vyas PM, et al. Among authors: woster pm. Biochem Pharmacol. 2005 Jul 15;70(2):275-86. doi: 10.1016/j.bcp.2005.04.023. Biochem Pharmacol. 2005. PMID: 15894292

3

Dapsone-induced hematologic toxicity: comparison of the methemoglobin-forming ability of hydroxylamine metabolites of dapsone in rat and human blood.

Vage C, Saab N, Woster PM, Svensson CK. Vage C, et al. Among authors: woster pm. Toxicol Appl Pharmacol. 1994 Dec;129(2):309-16. doi: 10.1006/taap.1994.1255. Toxicol Appl Pharmacol. 1994. PMID: 7992320

4

Methemoglobin formation by hydroxylamine metabolites of sulfamethoxazole and dapsone: implications for differences in adverse drug reactions.

Reilly TP, Woster PM, Svensson CK. Reilly TP, et al. Among authors: woster pm. J Pharmacol Exp Ther. 1999 Mar;288(3):951-9. J Pharmacol Exp Ther. 1999. PMID: 10027831

5

Comparison of the in vitro cytotoxicity of hydroxylamine metabolites of sulfamethoxazole and dapsone.

Reilly TP, Bellevue FH 3rd, Woster PM, Svensson CK. Reilly TP, et al. Among authors: woster pm. Biochem Pharmacol. 1998 Mar 15;55(6):803-10. doi: 10.1016/s0006-2952(97)00547-9. Biochem Pharmacol. 1998. PMID: 9586952 Clinical Trial.

6

Is hydroxylamine-induced cytotoxicity a valid marker for hypersensitivity reactions to sulfamethoxazole in human immunodeficiency virus-infected individuals?

Reilly TP, MacArthur RD, Farrough MJ, Crane LR, Woster PM, Svensson CK. Reilly TP, et al. Among authors: woster pm. J Pharmacol Exp Ther. 1999 Dec;291(3):1356-64. J Pharmacol Exp Ther. 1999. PMID: 10565861 Clinical Trial.

7

A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions.

Reilly TP, Lash LH, Doll MA, Hein DW, Woster PM, Svensson CK. Reilly TP, et al. Among authors: woster pm. J Invest Dermatol. 2000 Jun;114(6):1164-73. doi: 10.1046/j.1523-1747.2000.00985.x. J Invest Dermatol. 2000. PMID: 10844561 Free article.

8

A novel histone deacetylase inhibitor prevents IL-1beta induced metabolic dysfunction in pancreatic beta-cells.

Susick L, Senanayake T, Veluthakal R, Woster PM, Kowluru A. Susick L, et al. Among authors: woster pm. J Cell Mol Med. 2009 Aug;13(8B):1877-85. doi: 10.1111/j.1582-4934.2009.00672.x. J Cell Mol Med. 2009. PMID: 20141611 Free PMC article.

9

1-(N-alkylamino)-11-(N-ethylamino)-4,8-diazaundecanes: simple synthetic polyamine analogues that differentially alter tubulin polymerization.

Webb HK, Wu Z, Sirisoma N, Ha HC, Casero RA Jr, Woster PM. Webb HK, et al. Among authors: woster pm. J Med Chem. 1999 Apr 22;42(8):1415-21. doi: 10.1021/jm980603+. J Med Chem. 1999. PMID: 10212127

10

Synthesis and evaluation of unsymmetrically substituted polyamine analogues as modulators of human spermidine/spermine-N1-acetyltransferase (SSAT) and as potential antitumor agents.

Saab NH, West EE, Bieszk NC, Preuss CV, Mank AR, Casero RA Jr, Woster PM. Saab NH, et al. Among authors: woster pm. J Med Chem. 1993 Oct 1;36(20):2998-3004. doi: 10.1021/jm00072a020. J Med Chem. 1993. PMID: 8411017

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters